Pennsylvania 2025-2026 Regular Session

Pennsylvania House Bill HB1494

Introduced
5/21/25  

Caption

Providing for over-the-counter availability of ivermectin.

Companion Bills

No companion bills found.

Previously Filed As

PA SB1169

Further providing for definitions and for drug overdose medication.

PA HB2592

Further providing for drug overdose medication.

PA HB1661

Further providing for schedules of controlled substances; and providing for secure storage of xylazine.

PA HB2020

Further providing for drug overdose response immunity.

PA SB81

Further providing for definitions and for unlawful acts.

PA SB165

Further providing for prohibited acts and penalties.

PA HB1693

Providing for opioid settlements.

PA HB2363

Further providing for title and short title of act, for definitions, for establishment of program, for restocking and dispensing of cancer drugs, for storage, distribution and fees and for immunity, providing for annual report and for list of approved participating pharmacies and further providing for regulations.

PA HB1783

Providing for substance use overdose awareness, treatment and recovery support and for powers and duties of the Department of Drug and Alcohol Programs; and establishing the Lifetime Recovery from Substance Use Grant Program.

PA HB1993

Further providing for title of act; in preliminary provisions, further providing for short title, for scope of act and for definitions and providing for regulations; in pharmacy audits, further providing for limitations; in registration, further providing for PBM and auditing entity registration; providing for pharmacy benefits manager contracts; in PBM cost transparency requirements, providing for PBM transparency report required, repealing provisions relating to regulations and providing for PSAO reporting requirements; in enforcements, further providing for scope of enforcement authority; providing for pharmacy services; and making repeals.

Similar Bills

No similar bills found.